Back to funds
View filing
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC
hedge fundUpdated 27 days agoManaged by Summit Partners Public Asset Management, Llc • Latest filing Q2 2026
Portfolio value
$5.7B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
67.7%
Weight of largest holdings
Annualized return
28.2%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $2.4B |
| Q2 2023 | $2.7B |
| Q3 2023 | $2.3B |
| Q4 2023 | $2.4B |
| Q1 2024 | $2.9B |
| Q2 2024 | $2.6B |
| Q3 2024 | $3.2B |
| Q4 2024 | $5.2B |
| Q1 2025 | $3.9B |
| Q2 2025 | $4B |
| Q3 2025 | $4.8B |
| Q4 2025 | $4.8B |
| Q1 2026 | $3.7B |
| Q2 2026 | $5.7B |
Top holdings
155 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | H HODL VANECK ETF TRUST | $468.3M | 714.0K | 8.23% | — |
| 2 | S SNDK SANDISK CORP | $353.3M | 155.4K | 6.21% | — |
| 3 | G GH GUARDANT HEALTH INC | $145.2M | 967.7K | 2.55% | — |
| 4 | M MKSI MKS INC. | $142.3M | 319.8K | 2.50% | — |
| 5 | D DOCN DIGITALOCEAN HLDGS INC | $139.4M | 887.4K | 2.45% | — |
| 6 | S SEI SOLARIS ENERGY INFRAS INC | $136.2M | 1.69M | 2.39% | — |
| 7 | T TSEM TOWER SEMICONDUCTOR LTD | $134.9M | 517.5K | 2.37% | — |
| 8 | N NBIS NEBIUS GROUP N.V. | $124.1M | 449.4K | 2.18% | — |
| 9 | S SNOW SNOWFLAKE INC | $112.1M | 440.4K | 1.97% | — |
| 10 | H HUT HUT 8 CORP | $110.7M | 958.5K | 1.94% | — |
| 11 | N NTRA NATERA INC | $105.6M | 389.0K | 1.86% | — |
| 12 | D DDOG DATADOG INC | $103.4M | 397.0K | 1.82% | — |
| 13 | N NVDA NVIDIA CORPORATION | $90M | 450.0K | 1.58% | — |
| 14 | O ONTO ONTO INNOVATION INC | $87.8M | 232.0K | 1.54% | — |
| 15 | S SIMO SILICON MOTION TECHNOLOGY CO | $87.3M | 261.8K | 1.53% | — |
| 16 | S SNDK SANDISK CORP | $79.6M | 35.0K | 1.40% | — |
| 17 | S SITM SITIME CORP | $76.8M | 103.0K | 1.35% | — |
| 18 | D DELL DELL TECHNOLOGIES INC | $76.4M | 177.0K | 1.34% | — |
| 19 | K KLAC KLA CORP | $69.2M | 229.5K | 1.22% | — |
| 20 | A ARWR ARROWHEAD PHARMACEUTICALS IN | $67.7M | 830.2K | 1.19% | — |